Respiratory Medicine UK Medical PG Practice Questions and MCQs
Practice UK Medical PG questions for Respiratory Medicine. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Respiratory Medicine UK Medical PG Question 1: A 42-year-old woman presents with fatigue, muscle aches, and widespread pain. She has multiple tender points but normal inflammatory markers. Sleep is poor. What is the most appropriate initial treatment?
- A. NSAIDs
- B. Prednisolone
- C. Pregabalin (Correct Answer)
- D. Methotrexate
- E. Physiotherapy alone
Respiratory Medicine Explanation: ***Pregabalin***
- **Pregabalin** is a **gabapentinoid** drug that modulates voltage-gated calcium channels, decreasing the release of excitatory neurotransmitters involved in central pain sensitization characteristic of **fibromyalgia**.
- It is one of the FDA-approved medications (along with duloxetine and milnacipran) specifically recommended for managing the **widespread pain** and associated symptoms like **poor sleep** in fibromyalgia.
*NSAIDs*
- Non-steroidal anti-inflammatory drugs (NSAIDs) target inflammatory pain, which is generally absent in **fibromyalgia** as evidenced by **normal inflammatory markers**.
- NSAIDs are usually **ineffective** in treating the centralized pain and hyperalgesia seen in this condition, making them a poor choice for monotherapy.
*Prednisolone*
- **Prednisolone** is a powerful corticosteroid used for conditions driven by **inflammation** (e.g., active arthritis or vasculitis).
- The patient has normal inflammatory markers and a clinical presentation consistent with a non-inflammatory central pain syndrome, making steroids **inappropriate** and potentially harmful.
*Methotrexate*
- **Methotrexate** is a **Disease-Modifying Anti-Rheumatic Drug (DMARD)** indicated for managing autoimmune inflammatory diseases like **Rheumatoid Arthritis** or **Psoriatic Arthritis**.
- Since the patient does not show evidence of an inflammatory or autoimmune joint disease, this immunosuppressant drug treatment is **not warranted**.
*Physiotherapy alone*
- While non-pharmacological therapies like **aerobic exercise** and **Cognitive Behavioral Therapy (CBT)** are essential long-term components, they are often insufficient alone to manage severe initial symptoms, particularly **poor sleep** and disabling pain.
- Initial treatment typically requires a combination of pharmacological agents (like **Pregabalin**) combined with supportive non-pharmacological management for optimal symptom control.
Respiratory Medicine UK Medical PG Question 2: A 38-year-old woman presents with recurrent episodes of severe abdominal pain and psychiatric symptoms. Her urine turns dark during attacks. Family history reveals similar episodes. What is the inheritance pattern?
- A. Autosomal recessive
- B. Autosomal dominant (Correct Answer)
- C. X-linked recessive
- D. X-linked dominant
- E. Mitochondrial
Respiratory Medicine Explanation: ***Autosomal dominant***
- The clinical picture of recurrent severe abdominal pain, psychiatric symptoms, and dark urine during attacks is highly suggestive of **Acute Intermittent Porphyria (AIP)**.
- AIP is caused by a deficiency in **hydroxymethylbilane synthase (PBG deaminase)** and is inherited in an **autosomal dominant** fashion, which explains the positive family history.
*Autosomal recessive*
- **Autosomal recessive** disorders typically manifest if two copies of the defective gene are inherited, often presenting in siblings but not consistently across multiple generations (vertical transmission) as implied by the family history.
- Conditions like **Congenital erythropoietic porphyria** are autosomal recessive but primarily cause photosensitivity and hemolytic anemia, not neurovisceral crises.
*X-linked recessive*
- **X-linked recessive** disorders predominantly affect males and are transmitted from carrier mothers to sons, a pattern inconsistent with a female patient with similar episodes in the family.
- Common examples like **Hemophilia** or **Duchenne Muscular Dystrophy** have sex-linked inheritance patterns that do not match the presented symptoms or inheritance.
*X-linked dominant*
- **X-linked dominant** inheritance would show affected fathers passing the trait to all daughters but none of their sons, and affected mothers passing it to half of their children, which is not the typical pattern for AIP.
- **X-linked protoporphyria**, a rare porphyria, follows this pattern but presents primarily with severe photosensitivity and hepatobiliary complications, not the neurovisceral attacks seen here.
*Mitochondrial*
- **Mitochondrial inheritance** is characterized by exclusive **maternal transmission**, meaning all children of an affected mother are affected, but no children of an affected father. This pattern differs from the general family history for AIP.
- Mitochondrial disorders primarily affect high-energy-demand organs, and while they can have neurological components, most porphyrias are nuclear-encoded genetic disorders, making mitochondrial inheritance highly unlikely.
Respiratory Medicine UK Medical PG Question 3: A 28-year-old woman presents with sudden onset severe headache during exercise. She vomits and has neck stiffness. CT head shows subarachnoid hemorrhage. What is the most likely cause?
- A. Arteriovenous malformation
- B. Berry aneurysm (Correct Answer)
- C. Carotid dissection
- D. Hypertensive hemorrhage
- E. Trauma
Respiratory Medicine Explanation: ***Berry aneurysm*** - The sudden onset of a severe, explosive **thunderclap headache** coupled with signs of meningeal irritation (vomiting, neck stiffness) and the finding of **subarachnoid hemorrhage (SAH)** on CT head is the classic presentation of a ruptured saccular (**berry**) aneurysm. - Exertion (exercise) acts as a common trigger for aneurysm rupture due to the sudden increase in **intracranial pressure** and transmural wall stress. *Arteriovenous malformation* - AVMs more commonly present with **intraparenchymal hemorrhage** (ICH) or seizures, rather than isolated SAH, especially when triggered by exertion. - While AVMs can cause SAH, they are a less frequent cause of widespread spontaneous SAH compared to ruptured **berry aneurysms**. *Carotid dissection* - Carotid artery dissection typically manifests as severe neck/facial pain, headache, and signs of **cerebral ischemia** (stroke symptoms) due to vessel stenosis or occlusion. - Dissections rarely cause primary, widespread SAH; they are more often associated with **subintimal hemorrhage** leading to stroke or pseudoaneurysm formation. *Hypertensive hemorrhage* - Hemorrhage due to chronic or severe hypertension (hypertensive hemorrhage) almost exclusively causes deep **intraparenchymal hemorrhage** (ICH), usually in the basal ganglia, thalamus, or brainstem. - The primary finding of SAH, rather than ICH and the patient's young age, makes uncontrolled hypertension highly unlikely as the underlying cause. *Trauma* - Although trauma is the single most frequent overall cause of SAH, the clinical history describes a **spontaneous event** triggered by exertion (exercise) without any external injury. - Traumatic SAH is clinically differentiated by the history of a specific injury and usually involves bleeding adjacent to the site of impact.
Respiratory Medicine UK Medical PG Question 4: A 56-year-old man presents with progressive dyspnea and chest tightness. He works in coal mining. Chest X-ray shows bilateral upper lobe nodules. What is the most likely diagnosis?
- A. Lung cancer
- B. Silicosis
- C. Coal worker's pneumoconiosis (Correct Answer)
- D. Tuberculosis
- E. Sarcoidosis
Respiratory Medicine Explanation: ***Coal worker's pneumoconiosis***- This diagnosis is strongly supported by the patient's occupational exposure to **coal dust** and the progressive respiratory symptoms like **dyspnea** and **chest tightness**.- The characteristic Chest X-ray finding of bilateral, often small, **pulmonary nodules** predominantly located in the **upper lung zones** is classic for this condition.*Lung cancer*- Although coal miners have an increased risk of lung cancer, the presentation of diffuse **bilateral small nodules** is more typical of a pneumoconiosis than primary malignancy.- Lung cancer usually manifests as a single, dominant mass, or less commonly as reticulonodular interstitial disease, not typically as diffuse, symmetrical small nodules.*Silicosis*- Silicosis is caused by the inhalation of **crystalline silica** dust, prevalent in occupations like sandblasting or quarrying, which differs from pure coal mining exposure.- While silicosis also causes upper lobe nodules, it often presents radiologically with **"eggshell" calcification** of the hilar lymph nodes, a finding not specified in this case.*Tuberculosis*- Although **post-primary TB** targets the upper lobes, generalized diffuse nodularity suggests pneumoconiosis rather than a primary mycobacterial infection.- TB typically presents with systemic symptoms like **fever**, **night sweats**, and **weight loss**, which are not mentioned in this patient's presentation.*Sarcoidosis*- Sarcoidosis is a systemic disease of unknown etiology characterized by **non-caseating granulomas** and classically presents with **bilateral hilar lymphadenopathy (BHL)** on chest imaging.- The strong history of **coal mining** is the key factor favoring an occupational lung disease over sarcoidosis, as BHL is also absent.
Respiratory Medicine UK Medical PG Question 5: A 56-year-old man presents with progressive dyspnea and dry cough. HRCT shows bilateral lower lobe fibrosis with honeycombing. He has clubbing and restrictive spirometry. What medication may slow disease progression?
- A. Prednisolone
- B. Azathioprine
- C. Pirfenidone (Correct Answer)
- D. Cyclophosphamide
- E. N-acetylcysteine
Respiratory Medicine Explanation: ***Pirfenidone***- The clinical presentation with progressive dyspnea, dry cough, clubbing, restrictive spirometry, and HRCT showing bilateral lower lobe fibrosis with **honeycombing** is highly characteristic of **Idiopathic Pulmonary Fibrosis (IPF)**.- **Pirfenidone** is an **anti-fibrotic** agent, along with nintedanib, approved for the treatment of mild to moderate IPF to slow disease progression by reducing the decline in **Forced Vital Capacity (FVC)**.*Prednisolone*- Systemic corticosteroids like **Prednisolone** are not recommended as monotherapy for **Idiopathic Pulmonary Fibrosis (IPF)** due to lack of proven long-term efficacy and potential harm.- They are primarily indicated for inflammatory interstitial lung diseases, such as those associated with **connective tissue diseases**, or for **acute exacerbations** of IPF.*Azathioprine*- **Azathioprine** is an immunosuppressant that was shown to be ineffective and potentially harmful in a triple-drug regimen for IPF in the **PANTHER-IPF trial**.- Immunosuppression is generally avoided in **Idiopathic Pulmonary Fibrosis** unless there is a strong suspicion of an alternative, inflammatory interstitial lung disease.*Cyclophosphamide*- **Cyclophosphamide** is a potent cytotoxic immunosuppressant typically reserved for severe, rapidly progressive forms of **connective tissue disease-associated ILD** (e.g., scleroderma-associated ILD or vasculitis).- It is not indicated for the primary management of **Idiopathic Pulmonary Fibrosis**, which is characterized by relentless fibrosis rather than a primary inflammatory process responsive to this therapy.*N-acetylcysteine*- Although previously studied for its antioxidant properties, the **PANTHER-IPF trial** demonstrated that **N-acetylcysteine** offered no benefit in slowing the progression of IPF and is no longer recommended.- Its primary clinical uses are as a mucolytic agent and as an antidote for **acetaminophen overdose**.
Respiratory Medicine UK Medical PG Question 6: A 54-year-old man presents with progressive dyspnea and chest tightness. Spirometry shows FEV1 1.8L (60% predicted), FEV1/FVC 0.55. He has a 40 pack-year smoking history. What is the most important intervention?
- A. Bronchodilators
- B. Inhaled corticosteroids
- C. Smoking cessation (Correct Answer)
- D. Pulmonary rehabilitation
- E. Long-term oxygen therapy
Respiratory Medicine Explanation: ***Smoking cessation***- This is the **single most important intervention** for patients with **COPD** who smoke, as it is the only measure proven to slow the rate of **FEV1 decline** and disease progression.- Quitting smoking significantly reduces symptoms, exacerbations, and mortality, directly addressing the primary etiological factor in this patient's 40 pack-year history.*Bronchodilators*- **Bronchodilators** (e.g., beta-agonists, anticholinergics) provide crucial **symptomatic relief** by improving airflow and reducing dyspnea, but they do not alter the natural history of COPD or stop the underlying disease progression.- They are essential for managing symptoms but are not the **most important intervention** to halt the destruction caused by smoking.*Inhaled corticosteroids*- **Inhaled corticosteroids (ICS)** are typically indicated for patients with more severe COPD (e.g., FEV1 < 50% predicted) and a history of **frequent exacerbations**, often in combination with long-acting bronchodilators.- While they can reduce inflammation and exacerbation rates, ICS do not reverse or prevent the progressive lung damage caused by smoking.*Pulmonary rehabilitation*- **Pulmonary rehabilitation** is a highly effective intervention that improves **exercise capacity**, reduces dyspnea, and enhances quality of life in patients with COPD.- However, it does not modify the underlying **disease progression** or stop the decline in lung function, which is the primary benefit of smoking cessation.*Long-term oxygen therapy*- **Long-term oxygen therapy (LTOT)** is indicated for patients with **severe chronic hypoxemia** (PaO2 < 55 mmHg or SaO2 < 88%) to improve survival and quality of life.- This intervention addresses a consequence of advanced COPD but does not directly prevent or slow the progression of the disease itself, which is the focus of the question.
Respiratory Medicine UK Medical PG Question 7: A 58-year-old man presents with progressive dyspnea and fatigue. Chest X-ray shows bilateral lower lobe shadowing. HRCT shows honeycombing and traction bronchiectasis. He has finger clubbing. What is the prognosis?
- A. Excellent with treatment
- B. Good with early intervention
- C. Variable depending on cause
- D. Poor with median survival 2-5 years (Correct Answer)
- E. Benign condition
Respiratory Medicine Explanation: ***Poor with median survival 2-5 years***- The progressive dyspnea, fatigue, finger clubbing, and HRCT findings of **honeycombing** and **traction bronchiectasis** are classic features of **Idiopathic Pulmonary Fibrosis (IPF)**.- IPF is a relentlessly progressive lung disease with a **poor prognosis**, typically having a median survival of **2 to 5 years** from diagnosis without lung transplantation.*Excellent with treatment*- IPF is an **irreversible, progressive fibrotic lung disease** for which there is currently no curative medical treatment, precluding an excellent prognosis.- Although anti-fibrotic medications can slow the rate of decline, they do not halt or reverse the underlying **pulmonary fibrosis**.*Good with early intervention*- Despite early diagnosis and intervention with anti-fibrotic drugs, the established **Usual Interstitial Pneumonia (UIP)** pattern of IPF implies a rapid and unfavorable progression.- Patients with IPF remain at high risk of **acute exacerbations** and progressive **respiratory failure**, even with timely management.*Variable depending on cause*- The classic presentation of progressive dyspnea, clubbing, and a definable **UIP pattern** on HRCT points strongly to **Idiopathic Pulmonary Fibrosis**, which has a consistently unfavorable prognosis.- Prognostic variability is more often associated with other Interstitial Lung Diseases (ILDs) like non-specific interstitial pneumonia (**NSIP**), not IPF.*Benign condition*- IPF is far from benign; it is a serious, ultimately **fatal condition** characterized by continuous and irreversible destruction of lung architecture.- The presence of **traction bronchiectasis** and **honeycombing** signifies advanced, non-reversible scarring and distortion of lung tissue, indicating a severe disease.
Respiratory Medicine UK Medical PG Question 8: A 54-year-old man presents with progressive dyspnea and bilateral lower lobe crackles. Chest X-ray shows bilateral infiltrates. He works in shipbuilding. What is the most likely diagnosis?
- A. COPD
- B. Asbestosis (Correct Answer)
- C. Silicosis
- D. Coal worker's pneumoconiosis
- E. Hypersensitivity pneumonitis
Respiratory Medicine Explanation: ***Asbestosis***- The patient's history of working in **shipbuilding** is a classic exposure for **asbestos** fibers.- Asbestosis typically causes **interstitial pulmonary fibrosis**, preferentially affecting the **lower lobes**, leading to progressive dyspnea and **bibasilar crackles**. *COPD*- This involves **obstructive lung disease** (e.g., chronic bronchitis or emphysema) characterized by airflow limitation, not the restrictive pattern suggested by crackles and infiltrates.- CXR typically shows signs of **hyperinflation** or large bullae, rather than diffuse bilateral interstitial infiltrates.*Silicosis*- Silicosis is caused by inhaling **free crystalline silica** (e.g., mining, quarrying, sandblasting), an exposure typically unrelated to shipbuilding.- Radiographically, silicosis usually presents with **nodular opacities**, classically affecting the **upper lobes**.*Coal worker's pneumoconiosis*- This condition is due to the inhalation of **coal dust**, almost exclusively seen in **coal miners**.- Simple CWP generally causes small **nodular opacities**, also predominantly in the **upper lung fields**.*Hypersensitivity pneumonitis*- Caused by immunologic reactions to inhaled **organic antigens** (e.g., bird droppings, mold from farmers' lung), not asbestos exposure.- HP often presents with systemic symptoms, and the pathology involves the **alveolar walls** and terminal bronchioles, lacking the specific pleural/parenchymal changes linked to asbestos.
Respiratory Medicine UK Medical PG Question 9: A 56-year-old man presents with progressive dyspnea and dry cough. HRCT shows honeycombing and traction bronchiectasis in lower lobes. He has clubbing. What is the most likely diagnosis?
- A. COPD
- B. Asthma
- C. Idiopathic pulmonary fibrosis (Correct Answer)
- D. Sarcoidosis
- E. Hypersensitivity pneumonitis
Respiratory Medicine Explanation: ***Idiopathic pulmonary fibrosis***- The clinical presentation of **progressive dyspnea**, **dry cough**, and **clubbing** in an older patient, coupled with HRCT findings of **honeycombing** and **traction bronchiectasis** predominantly in the **lower lobes**, are classic features of **Usual Interstitial Pneumonia (UIP)** pattern, diagnostic of IPF.- **UIP** pattern on HRCT signifies extensive subpleural and basilar fibrosis with architectural distortion, where **honeycombing** represents clustered cystic airspaces and **traction bronchiectasis** indicates bronchial dilation due to surrounding fibrotic retraction.*COPD*- **COPD** is characterized by persistent **airflow limitation**, often with a history of smoking and a productive cough, contrasting with the dry cough and restrictive pattern of fibrosis seen here.- HRCT in COPD typically shows **emphysema** (centrilobular or panlobular) or **airway wall thickening**, but not the **honeycombing** and **traction bronchiectasis** indicative of severe pulmonary fibrosis.*Asthma*- **Asthma** is an inflammatory airway disease marked by **reversible airflow obstruction** and bronchial hyperresponsiveness, presenting with episodic wheezing, chest tightness, and dyspnea, which usually respond to bronchodilators.- HRCT in asthma may show **bronchial wall thickening** or **air trapping**, but it does not exhibit the progressive fibrotic changes like **honeycombing** or **traction bronchiectasis** seen in this patient.*Sarcoidosis*- **Sarcoidosis** is a multisystem granulomatous disease, often involving the lungs with **bilateral hilar lymphadenopathy** and a **perilymphatic distribution** of nodules, typically in the upper and mid lung zones.- While sarcoidosis can cause fibrosis (Stage 4), it typically manifests as **upper lobe predominant fibrosis** with conglomerate masses and volume loss, rather than the lower lobe predilection and characteristic UIP pattern.*Hypersensitivity pneumonitis*- Chronic **hypersensitivity pneumonitis (HP)** can lead to fibrosis, but HRCT often reveals a mosaic attenuation pattern, **centrilobular nodules**, and **air trapping**, with fibrosis potentially sparing the subpleural regions.- Although HP can mimic a UIP pattern in some cases, the classic presentation of progressive dyspnea, dry cough, clubbing, and strict lower lobe **honeycombing** and **traction bronchiectasis** points more strongly to IPF.
Respiratory Medicine UK Medical PG Question 10: A 42-year-old man presents with progressive dyspnea and chest tightness. Spirometry shows FEV1 45% predicted, FEV1/FVC 0.85. HRCT shows lower lobe fibrosis. What is the most likely diagnosis?
- A. COPD
- B. Asthma
- C. Interstitial lung disease (Correct Answer)
- D. Bronchiectasis
- E. Pneumothorax
Respiratory Medicine Explanation: ***Interstitial lung disease***- This pattern—low FEV1 (45% predicted) with a preserved FEV1/FVC ratio (0.85)—is characteristic of a **restrictive ventilatory defect**, where **lung volumes** are reduced due to stiff lungs.- The HRCT finding of **lower lobe fibrosis** directly confirms a restrictive pathology and is a hallmark of many Interstitial Lung Diseases (ILDs), such as **Idiopathic Pulmonary Fibrosis (IPF)**.*COPD*- COPD is an **obstructive lung disease** characterized by a **reduced FEV1/FVC ratio**, typically less than 0.70, which contradicts the given ratio of 0.85.- While it causes dyspnea, the primary HRCT findings are **emphysema** (centrilobular or panlobular) or **airway wall thickening**, not primarily lower lobe fibrosis.*Asthma*- Asthma is also an **obstructive lung disease** with variable and reversible airflow limitation, meaning the FEV1/FVC ratio would be **reduced**, often improving with bronchodilators.- HRCT findings in asthma might show **airway wall thickening** or **hyperinflation**, but it does not cause **pulmonary fibrosis**.*Bronchiectasis*- Bronchiectasis is characterized by permanent **dilation of the bronchi** and often presents with a chronic cough and sputum production.- Spirometry typically shows an **obstructive or mixed ventilatory defect**, not a purely restrictive pattern with a preserved FEV1/FVC ratio. HRCT shows **dilated airways** ("tram tracks" or "signet ring sign").*Pneumothorax*- A pneumothorax is the presence of **air in the pleural space**, causing acute dyspnea and chest pain, and resulting in a **collapsed lung** on imaging.- Spirometry would show severely reduced lung volumes, but the HRCT finding of **lower lobe fibrosis** is inconsistent with a pneumothorax, which is an acute air leak.
More Respiratory Medicine UK Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
